Evidence map›Paper›PMID 42655000›Full record

ArticleMicroorganisms2026

Synergic Effect of Fluconazole and Quinoline Derivatives Combination Against

Luana Candice Genz Bazana, Ânderson Ramos Carvalho, Rodrigo Foss da Silva, Solange Cristina Garcia, Marcelo Dutra Arbo, Mario Lettieri Teixeira, Alexandre Meneghello Fuentefria

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luana Candice Genz BazanaLaboratório de Pesquisa em Micologia Aplicada, Universidade Federal do Rio Grande do Sul, Porto Alegre 90620-170, RS, Brazil.ORCID 0000-0002-3495-094X
Ânderson Ramos CarvalhoLaboratório de Pesquisa em Micologia Aplicada, Universidade Federal do Rio Grande do Sul, Porto Alegre 90620-170, RS, Brazil.ORCID 0000-0002-3879-9650
Rodrigo Foss da SilvaPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre 90160-093, RS, Brazil.
Solange Cristina GarciaPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre 90160-093, RS, Brazil.ORCID 0000-0003-3752-5751
Marcelo Dutra ArboPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre 90160-093, RS, Brazil.ORCID 0000-0002-0434-1553
Mario Lettieri TeixeiraLaboratório de Pesquisa em Toxicologia e Farmacologia, Instituto Federal Catarinense, Concórdia 89703-720, SC, Brazil.ORCID 0000-0003-4546-5584
Alexandre Meneghello FuentefriaLaboratório de Pesquisa em Micologia Aplicada, Universidade Federal do Rio Grande do Sul, Porto Alegre 90620-170, RS, Brazil.ORCID 0000-0003-2979-4417

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001
6 · The paper itself

Abstract

Cryptococcosis is a severe fungal infection affecting immunocompromised individuals, with treatment limited to FLZ, AMB, and FC. This study investigated the antifungal potential of fluconazole (FLZ)-, amphotericin B (AMB)-, 8-hydroxyquinoline (8HQ)-, and clioquinol (CQ)-based combinations against

Indexed as

amphotericin Bantifungal combinationcheckerboard assaycryptococcal infectionCryptococcus spp.fluconazolemetal chelator

Identifiers

PMID42655000
PMCPMC13515043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.